The current PE ratio for Cme Group stock as of Mar 28, 2025 is 27.06. This is calculated based on the current EPS of $9.69 and the stock price of $262.22 per share. The P/E ratio has an increase of 16% from the past four quarters average of 23.3.
The average historical PE ratio of Cme Group for the last ten years is 26.07. The current PE ratio of 27.06 is 3.8% above the historical average. In the past ten years, CME's PE ratio was at its highest in the Jun 2021 quarter at 39.75, when the stock price was $212.68 and the EPS was $5.35. The lowest value was in the Dec 2017 quarter, when it reached 12.17 with a price of $146.05 and an EPS of $12.
Maximum annual increase: 169.76% in 2018
Maximum annual decrease: -60.12% in 2011
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 23.97 | 0.97% | $232.23 | $9.69 |
2023 | 23.74 | 4.63% | $210.6 | $8.87 |
2022 | 22.69 | -27.51% | $168.16 | $7.41 |
2021 | 31.3 | 1.1% | $228.46 | $7.3 |
2020 | 30.96 | -8.54% | $182.05 | $5.88 |
2019 | 33.85 | 3.11% | $200.72 | $5.93 |
2018 | 32.83 | 169.76% | $188.12 | $5.73 |
2017 | 12.17 | -51.99% | $146.05 | $12 |
2016 | 25.35 | 3.81% | $115.35 | $4.55 |
2015 | 24.42 | -7.18% | $90.6 | $3.71 |
2014 | 26.31 | -1.42% | $88.65 | $3.37 |
2013 | 26.69 | 42.73% | $78.46 | $2.94 |
2012 | 18.7 | 109.17% | $50.67 | $2.71 |
2011 | 8.94 | -60.12% | $48.73 | $5.45 |
2010 | 22.42 | -16.9% | $64.35 | $2.87 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Dec 2024 | 23.97 | 3.54% | $232.23 | $9.69 |
Sep 2024 | 23.15 | 6.93% | $220.65 | $9.53 |
Jun 2024 | 21.65 | -11.6% | $196.6 | $9.08 |
Mar 2024 | 24.49 | 3.16% | $215.29 | $8.79 |
Dec 2023 | 23.74 | -0.5% | $210.6 | $8.87 |
Sep 2023 | 23.86 | 5.58% | $200.22 | $8.39 |
Jun 2023 | 22.6 | -7% | $185.29 | $8.2 |
Mar 2023 | 24.3 | 7.1% | $191.52 | $7.88 |
Dec 2022 | 22.69 | -5.97% | $168.16 | $7.41 |
Sep 2022 | 24.13 | -5% | $177.13 | $7.34 |
Jun 2022 | 25.4 | -18.2% | $204.7 | $8.06 |
Mar 2022 | 31.05 | -0.8% | $237.86 | $7.66 |
Dec 2021 | 31.3 | 9.9% | $228.46 | $7.3 |
Sep 2021 | 28.48 | -28.35% | $193.38 | $6.79 |
Jun 2021 | 39.75 | 3.92% | $212.68 | $5.35 |
The current PE ratio of CME is greater than its 3, 5 and 10-year historical averages.
CME's PE ratio is lower than its peer stocks ICE and MSCI.
Stock name | PE ratio | Market cap |
---|---|---|
CME Cme Group Inc | 27.37 | $95.57B |
CBOE Cboe Global Markets Inc | 31.22 | $23.67B |
ICE Intercontinental Exchange Inc | 35.94 | $99.11B |
NDAQ Nasdaq Inc | 39.11 | $43.64B |
MSCI MSCI Inc | 39.6 | $43.33B |
CME's price to earnings ratio is 27.06 as of Mar 28, 2025.
Over the last 3 years, the average price to earnings ratio for CME stock is 23.63.
Over the last 5 years, the average price to earnings ratio for CME stock is 26.95.
In the last ten years, the Jun 2021 quarter recorded the highest quarterly PE ratio at 39.75.
The current price to earnings ratio of CME is 3.8% higher than the 10-year historical average.
The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Mar 28, 2025), Cme Group's stock price is $262.22. The earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $9.69. Therefore, Cme Group's P/E ratio for today is 27.06. PE RATIO(27.06) = STOCK PRICE($262.22) / TTM EPS($9.69)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.